The changing face of cardiovascular risk

被引：32

作者：

Grundy, SM

机构：

[1] Univ Texas, SW Med Ctr, Ctr Human Nutr, Dept Clin Nutr & Internal Med, Dallas, TX 75390 USA

[2] Univ Texas, SW Med Ctr, Vet Affairs Med Ctr, Dallas, TX 75390 USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2005年 / 46卷 / 01期

关键词：

D O I：

10.1016/j.jacc.2005.05.007

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：173 / 175

页数：3

共 8 条

[1] Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E - The St. Francis Heart Study Randomized Clinical Trial [J].

Arad, Y ;

Spadaro, LA ;

Roth, M ;

Newstein, D ;

Guerci, AD .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (01) :166-172

[2] Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events - The St. Francis Heart Study [J].

Arad, Y ;

Goodman, KJ ;

Roth, M ;

Newstein, D ;

Guerci, AD .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (01) :158-165

[3] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report [J].

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, R ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Cleeman, JI ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ ;

Keller, SA ;

Jehle, AJ .

CIRCULATION, 2002, 106 (25) :3143-3421

[4] Intensive lipid lowering with atorvastatin in patients with stable coronary disease [J].

LaRosa, JC ;

Grundy, SM ;

Waters, DD ;

Shear, C ;

Barter, P ;

Fruchart, J ;

Gotto, AM ;

Greten, H ;

Kastelein, JJP ;

Shepherd, J ;

Wenger, NK .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (14) :1425-1435

[5]

PEDERSEN TR, 1994, LANCET, V344, P1383

[6] The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels [J].

Sacks, FM ;

Pfeffer, MA ;

Moye, LA ;

Rouleau, JL ;

Rutherford, JD ;

Cole, TG ;

Brown, L ;

Warnica, JW ;

Arnold, JMO ;

Wun, CC ;

Davis, BR ;

Braunwald, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1001-1009

[7] Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial [J].

Sever, PS ;

Dahlöf, B ;

Poulter, NR ;

Wedel, H ;

Beevers, G ;

Caulfield, M ;

Collins, R ;

Kjeldsen, SE ;

Kristinsson, A ;

McInnes, GT ;

Mehlsen, J ;

Nieminen, M ;

O'Brien, E ;

Östergren, J .

LANCET, 2003, 361 (9364) :1149-1158

[8]

Tonkin A, 1998, NEW ENGL J MED, V339, P1349

← 1 →